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well documented. The aim of this study is to estimate levels of smoking persistence
across 21 countries with a hypothesized inverse relationship between country
income level and smoking persistence.
Methods: Data from the World Health Organization World Mental Health Survey
Initiative were used to estimate cross-national differences in smoking persistence—
the proportion of adults who started to smoke and persisted in smoking by the date
of the survey.
Results: There is large variation in smoking persistence from 25% (Nigeria) to 85%
(China), with a random-effects meta-analytic summary estimate of 55% with consid-
erable cross-national variation. (Cochrans heterogeneity Q statistic = 6845;
p < 0.001). Meta-regressions indicated that observed differences are not attribut-
able to differences in countrys income level, age distribution of smokers, or how
recent the onset of smoking began within each country.
Conclusion: While smoking should remain an important public health issue in any
country where smokers are present, this report identifies several countries with
higher levels of smoking persistence (namely, China and India).
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Cigarette smoking (hereinafter referred to as
smoking) continues to be one of the leading
causes of preventable global mortality [1]. Global
surveillance of smoking activity continues to be
an important task in an effort to reduce this burden
[2]. The Global Youth Tobacco Survey estimated
that one third of the worlds 13–15 year olds had
ever smoked a cigarette, and an estimated one
fourth of these had done so before their 10th birth-
day [3]. The World Health Organization Framework
Convention on Tobacco Control (WHO FCTC) was
established to halt the global tobacco epidemic in
2003. This treaty has currently been ratified by
174 parties, 120 of which have adopted or strength-
ened their tobacco regulation legislation [4,5].
Article 20 of the WHO FCTC places particular
emphasis on the need for standardized tobacco
An updated global picture of cigarette smoking persistence among adults 137use surveillance for the purpose of cross-national
comparisons.
In a recent report by Storr et al., cross-national
estimates for smoking prevalence were presented
based on results from the first 17 sites of the World
Mental Health Surveys Initiative (WMHS) [6]. The
prevalence of current smoking ranged from 3.9%
(Nigeria) to 36.0% (Lebanon) within the countries
studied. Here, a more complete view of this global
smoking experience is sought, with new analyses
and new data from all 21 WMH sites with a focus
on smoking persistence.
The two main parameters affecting the preva-
lence of a condition are the incidents of the condi-
tion (the rate at which people are becoming new
cases) and the duration of the condition, thus any
difference in smoking prevalence might be owing
to a difference in smoking initiation, smoking per-
sistence or a combination of the two. This study fo-
cused on smoking persistence. Prior research
documented a relatively steady increase in smoking
prevalence in many low to middle income countries
of the world during the twentieth century [2], con-
current with relatively more stable or declining
prevalence elsewhere [7,8]. Accordingly, this study
was approached with an implicit hypothesis that
there might be an inverse relationship between
the general income level of a country and its level
of smoking persistence (i.e., smokers in lower in-
come countries in this report might be more likely
to persist in smoking, once smoking starts, as com-
pared with smokers in the higher income countries).
2. Methods
WMHS methods have been described in detail else-
where [6,9–11]. In brief, the cross-sectional sur-
veys have a mental health focus, and their main
goal has been to estimate the prevalence and im-
pact of psychiatric disorders worldwide using a
common survey protocol [10,11]. Adult designated
respondents (DRs) at each site were recruited for
standardized assessments after multi-stage com-
munity probability sampling, with participation
levels generally at 70%–80%. Most surveys were
nationally representative; however, this was infea-
sible in certain countries. The samples of Nigeria,
Mexico and Colombia were representative of 57%,
73% and 73% of their populations, respectively. In
addition, the samples from India, Japan and China
were representative of large metropolitan areas.
Attempts were made to recruit as many countries
as possible; however, the final sample reflects
countries with collaborators able to obtain funding
for the survey. All surveys were conducted from2001–2008. Site sample sizes ranged from 2357
(Romania) to 12,992 (New Zealand), with 101,392
DRs in the aggregate sample. A list of all countries
as well as each countrys sample size and income
level can be found in Table 1. All sites except
Japan surveyed subjectsP18 years old (Japan sur-
veyed subjects P20 years old). Columbia and Mex-
ico did not survey adults >65 years old while all
other sites had no age limit. Language variations
across countries prompted methods designed for
multi-national and cross-cultural research [12].
All protocols were approved by institutional review
boards for protection of human subjects across all
sites.
Assessments required ever-smokers to charac-
terize themselves as current or former smokers.
For each site, the proportion of ever-smokers
who qualified as current smokers at the assessment
(i.e., persistent smokers) was estimated, while
addressing survey weighting and complex sampling
design features (SAS v9.1.3). This was ascertained
by the question: ‘‘Are you a current, former or
never-smoker?’’ The question was only asked in
reference to cigarette smoking. The smoking per-
sistence proportion was defined as the number of
current smokers divided by the number of (current
smokers plus former smokers). The point of inter-
est with respect to this study was the differences
in smoking persistence for the following reason:
smoking prevalence changes in relation to smoking
incidents and average smoking duration (which is a
function of both smoking persistence and smoking
mortality). As described above, much is known
about the global distribution of smoking preva-
lence, however, less is known about whether high
smoking prevalence in an area might be owing to
a high number of persons starting to smoke or a
high proportion of smokers persisting in smoking.
Observed levels of smoking persistence might
differ owing to how recently smoking had become
a phenomenon within each country. It was assumed
that an individual who started to smoke 5 years
prior to assessment would be more likely to be a
current smoker than an individual who started to
smoke 25 years prior to the assessment. As a con-
trol for this, the researchers for this study strati-
fied the elapsed time since the onset of smoking
(>10 years versus 610 years). Unfortunately, infor-
mation on the age of first cigarette was only avail-
able for 12 countries. In an attempt to control this
problem across all sites, the researchers also strat-
ified across birth cohorts (post- vs. pre-Second
World War). Here, the assumption is that older
smokers have had a greater elapsed time since
smoking onset than younger smokers, as smoking
Table 1 Estimated smoking persistence among adults, by site, stratified by birth cohort and elapsed time since smoking
onset (estimated % with 95% confidence intervals).*Data from the World Mental Health Surveys Consortium, 2001–2008.
Country (sample size;
n of ever smokers)
Birth Cohort Elapsed time since
smoking onset
Sex
Pre-1945 Post-1945 >10 years 610 years Male Female
Nigeriac (n = 6752; 1137) 13 (8, 18) 31 (27, 35) 21 (15, 26) 32 (12, 51) 27 (23, 31) 24 (6, 42)
Colombiab (n = 4426; 2087) 22 (14, 30) 40 (37, 43) 39 (36, 43) 38 (32, 45) 39 (35, 44) 36 (31, 40)
Mexicob (n = 5782; 3276) 30 (22, 38) 44 (41, 47) 46 (42, 49) 42 (38, 47) 48 (44, 51) 35 (30, 39)
New Zealanda (n = 12,992; 6855) 23 (21, 25) 54 (52, 55) N/A N/A 46 (43, 48) 47 (44, 49)
United Statesa (n = 9282; 4835) 28 (26, 30) 55 (53, 56) 51 (47, 55) 63 (52, 75) 48 (46, 50) 47 (45, 49)
Northern Irelanda (n = 4340; 2074) 33 (29, 37) 60 (57, 63) N/A N/A 48 (44, 52) 57 (53, 60)
Belgiuma (n = 2419; 1234) 34 (28, 40) 59 (54, 64) N/A N/A 53 (49, 58) 52 (46, 58)
Brazilb (n = 5211; 2120) 35 (31, 39) 57 (54, 60) 52 (48, 56) 67 (48, 86) 51 (48, 55) 55 (53, 58)
Francea (n = 2894; 1502) 27 (21, 33) 61 (59, 63) N/A N/A 52 (49, 56) 55 (51, 59)
Netherlandsa (n = 2372; 1453) 35 (30, 40) 61 (57, 65) N/A N/A 51 (47, 55) 56 (52, 60)
Japana (n = 3417; 1623) 39 (34, 44) 63 (59, 67) N/A N/A 57 (53, 60) 50 (45, 57)
Italya (n = 4712; 2295) 35 (30, 40) 67 (65, 69) N/A N/A 54 (51, 57) 65 (61, 68)
Germanya (n = 3555; 1833) 33 (26, 40) 71 (68, 74) N/A N/A 59 (55, 63) 64 (59, 69)
Romaniab (n = 2357; 866) 47 (39, 55) 68 (63, 72) 65 (60, 71) 71 (60, 82) 62 (57, 68) 68 (61, 75)
Spaina (n = 5473; 2796) 36 (31, 41) 74 (72, 76) N/A N/A 58 (55, 62) 75 (73, 78)
Ukrainec (n = 4725; 1911) 46 (42, 50) 77 (74, 80) 74 (69, 80) 66 (55, 78) 73 (70, 76) 63 (60, 66)
South Africab (n = 4315; 1375) 49 (42, 56) 76 (73, 79) 84 (80, 87) 66 (60, 72) 73 (70, 77) 70 (66, 74)
Bulgariab (n = 5318; 2610) 46 (41, 51) 80 (78, 82) 73 (69, 76) 85 (79, 92) 72 (69, 75) 77 (74, 80)
Indiac (n = 2992; 369) 71 (61, 81) 76 (70, 82) 68 (58, 78) 82 (55, 100) 77 (72, 82) 55 (36, 74)
Lebanonb (n = 2857; 1439) 56 (49, 63) 83 (80, 86) 79 (72, 85) 92 (83, 100) 77 (73, 81) 78 (73, 83)
Chinac (n = 5201; 2001) 55 (48, 62) 87 (85, 89) 80 (76, 84) 86 (72, 100) 83 (81, 85) 77 (70, 85)
Meta-analytic summary: 37 (33,
42)1
64 (58,
70)2
61 (51,
71)3
66 (55, 77)4 57 (60,
64)5
58 (52, 63)6
* Here, the estimates are for the proportion of all smokers who were also current smokers on the date of assessment. Sites are
listed in ascending order according to their unadjusted persistence estimates. Data from Israel are not included owing to a
difference in assessment of smoking. Elapsed time since smoking onset stratification is not available for sites that did not ask about
the age of smoking onset.
1 Tests for heterogeneity: Cochrans Q (df = 20) = 410; p < 0.001.
2 Tests for heterogeneity: Cochrans Q (df = 20) = 2133; p < 0.001.
3 Tests for heterogeneity: Cochrans Q (df = 11) = 240; p < 0.001.
4 Tests for heterogeneity: Cochrans Q (df = 11) = 912; p < 0.001.
5 Tests for heterogeneity: Cochrans Q (df = 20) = 2276; p < 0.001.
6 Tests for heterogeneity: Cochrans Q (df = 20) = 869; p < 0.001.
a High income country.
b Upper-middle income country.
c Lower-middle income country.
138 J.P. Troost et al.generally begins at adolescence and early adult-
hood [13,14].
The researchers also tested for global gender dif-
ferences in smoking persistence to complement re-
cent estimates of global gender differences in
smoking prevalence with the hypothesis that there
are nomale/female differences on a global scale [6].
In addition, a series of meta-regressions were
conducted in order to evaluate whether a countrys
birth cohort distribution or how recent the onset of
distribution might serve as useful predictors of the
cross-national heterogeneity in smoking persis-
tence estimates.
Homogeneity in summary estimates was sought
by stratifying across high- and low-income coun-
tries (as defined by the World Bank) [15]. In addi-tion, income as a covariate in the meta-
regressions mentioned above was tested.
Meta-analyses were conducted in STATA using
the meta command. Random effects models were
used in order to address between-study heteroge-
neity and to reduce variations owing to unequal
sample size [16]. Cross-national heterogeneity
was gauged via the Q statistic where a significant
test indicates significant heterogeneity [17]. In
the meta-analysis, each countrys estimate was
weighted by the inverse of its variance.
Meta-regressions were accomplished in STATA
using the metareg command. In these analyses,
the additive between study variance (T2) statistics
was estimated using an iterative restricted maxi-
mum likelihood procedure [18].
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Table 1 is a display of each sites total sample size as
well as the sample size of ever-smokers. The overall
sample sizes ranged from 2357 (the Netherlands) to
12,992 (New Zealand) with an aggregate sample of
101,392 persons across all sites. The sample size
of ever-smokers across sites ranged from 369 (India)
to 6855 (New Zealand) with a total of 45,691 ever-
smokers used in this analysis; 45% of the individuals
from the total sample were ever-smokers and the
focus of the analysis. Nonsmokers were included
in the analysis for variance estimation.
The main estimates of this study are shown in
Fig. 1. This forest plot shows each countrys esti-
mated proportion of persistent smokers and the
95% confidence interval of those estimates. Esti-
mates ranged from 27% in Nigeria to 84% in China
with a random-effects summary estimate of 55%.
Considerable variation in smoking persistence was
found across countries (Cochrans heterogeneity
for Fig. 1. Q = 6845; p < 0.001).
Table 1 also displays persistence estimates and
95% confidence intervals, with stratifications by
birth cohort, elapsed time since smoking onset,
and sex. The countries are listed from the lowest
to the highest level of persistence before stratifica-
tion (as in Fig. 1). Within each stratum, the rank
ordering of sites (in order of persistence) is wellFigure 1 Forest plot for smoking persistence estimates am
Surveys Consortium, 2001–2008.preserved. For example, Nigeria has the lowest
persistence estimate across all strata; China has
among the highest persistence estimate across all
strata. As with the un-stratified meta-analysis,
there is a considerable amount of cross-national
heterogeneity within each stratum.
It was tested whether improved homogeneity
might be attained by collapsing countries into their
income categories (as defined by the World Bank).
Among the 10 high-income countries, the smoking
persistence estimates ranged from 46% in New Zea-
land to 65% in Spain; there was a random-effects
summary estimate of 54% (95% confidence interval,
CI = 50%, 59%; Cochrans heterogeneity Q = 431;
p < 0.001). Among the seven upper-middle income
countries, the corresponding smoking persistence
estimates ranged from 38% in Colombia to 77% in
Lebanon, with a random-effects summary estimate
of 60% (95% CI = 48%, 72%; Cochrans heterogeneity
Q = 1529; p < 0.001). Among the 4 lower-middle in-
come countries, the smoking persistence estimates
ranged from 28% in Nigeria to 84% in China, with a
random-effects summary estimate of 64% (95%
CI = 36%, 93%; Cochrans heterogeneity Q = 4637;
p < 0.001).
The meta-regression results can be found in the
Web-only Appendix. Table A2 presents the results
of the meta-regression. Country income level,
birth cohort distribution, and how recent the onsetong adults, by site.* Data from the World Mental Health
140 J.P. Troost et al.of smoking distribution were not found to be statis-
tically significant predictors of the smoking preva-
lence values observed for each country that
participated in the WMHSI. (The distribution of
these covariates for each country can be found in
Table A1.)4. Discussion
These findings indicate considerable cross-national
variation in smoking persistence estimates. The
rank ordering of high to low persistence did not
change appreciably with stratification by country
income level, birth cohort, elapsed time since
smoking onset, or sex (i.e., countries who were
ranked high or low in terms of persistence prior to
stratification remained high or low respectively
within each of the stratifications). Hence, within
study evidence limits, investigation of other sources
of variation is needed (e.g., cigarette nicotine con-
tent, taxation policies, and access to effective pre-
vention and smoking cessation aids) [19–22]. Cross-
national differences of the effectiveness of ciga-
rette-warning labels are also a possibility [23].
Several limitations deserve mention before a de-
tailed discussion of the study results. These include
the use of self-report assessments, a limited smok-
ing status question (e.g., ‘‘Are you a current, for-
mer or never-smoker?’’), exclusion of non-
cigarette smoked tobacco products (e.g., water
pipes, bidis) and this studys use of proportions
to summarize a time-to-event process because
age at quitting values was not assessed. In addi-
tion, there were no data on how recently an indi-
vidual had become a smoker in each country, and
this elapsed time since onset stratification was
limited to 12 countries. However, the researchers
attempted to address this across all countries by
stratifying by birth cohort. It is also possible that
cross-national differences in reporting bias could
also exist (where smokers in some countries are
more likely to report on their smoking than smok-
ers in other countries). While these limitations
are worth mentioning, they are common to most
studies on this topic.
With respect to the birth cohort stratification,
there is a clear selection bias among the pre-Second
World War cohorts (many individuals from these co-
horts died by the time these surveys were con-
ducted—some from tobacco-related diseases). This
will obviously bias comparisons between the pre-
and post-Second World War strata. However, the
goal was instead to compare countries within strata.
A counterbalancing strength is the ability to as-
sess smoking persistence on a global scale, amongadults in countries with different income levels.
While the Global Youth Tobacco Survey and the
Global Adult Tobacco Survey (both Centers for Dis-
ease Control Prevention [CDC] initiatives part of
the Global Tobacco Surveillance System [GTSS])
are both valuable resources, the former is limited
to 13–15 year olds and the later was only con-
ducted in 14 lower-income countries [23,24]. Other
strengths include epidemiological sampling of
adults which addresses the bias found in clinical re-
search on help-seeking smokers, as well as the use
of a well-translated standardized assessment.
These findings add to a growing body of research
on smoking persistence in a context that seeks a
more complete global view of the epidemiological
dynamics of smoking [6,9,25,26].
In terms of the public health implications of this
work, it is important to consider the primary find-
ing of this study: the large amount of cross-national
variation in smoking persistence found by the
Q-statistic.
Also, our meta-analytic summary estimates indi-
cate no male–female variation in smoking persis-
tence, but given the heterogeneity across
countries, it may be that male–female differences
may exist in individual countries (such as Mexico
and the Ukraine as reported in this study). On a glo-
bal scale, it may be difficult to identify high-risk
populations (such as male vs. female) for interven-
tions that can be considered high risk across all
countries. Still, the absence of a global male–fe-
male difference in smoking persistence is consis-
tent with similar research on the topic among
youth [3].
This report can, perhaps, shed light on which
countries are in the greatest need of smoking ces-
sation initiatives. For example, China and India,
two of the most populous countries in the world
each with emerging economies, had alarmingly
high rates of smoking persistence. While smoking
persistence is an important public issue in any
country where smokers may be found, perhaps it
is important for public health professionals to pay
particular attention to certain countries identified
in this report. It is difficult to determine from this
study why countries, such as China and India, have
such high levels of persistence. As shown by the
overlapping meta-analytic summary estimates for
each income level, it can be concluded that a coun-
trys income level is not a valid predictor of its
smoking persistence. Future analyses could instead
consider the income level of the individual smokers
instead of the overall income level of the country.
Previous research on the high rates of smoking per-
sistence in China has suggested one problem that
few individuals in China plan on quitting smoking
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outcomes [27,28]. Higher persistence in these
countries could also be owing to limited access to
smoking cessation aides [7], although data from
the American Cancer Societys Tobacco Atlas sug-
gest that Chinese smokers have access to nicotine
replacement therapy and some clinical cessation
services with costs covered [29]. Still, it is impor-
tant to remember that this study only measured
cigarette smoking. Particularly in countries such
as India, this is a limitation because of the added
complexity of other types of tobacco use, such as
bidis, water-pipe tobacco and smokeless tobacco
[30].
These findings may also provide useful insight in
conjunction with a conceptual model of smoking
epidemics developed by Lopez and colleagues
[31]. Briefly, this model posits a three to four dec-
ade lag between the peak in smoking prevalence
and a subsequent peak in smoking-related mortal-
ity. The model divides this process into four stages
of development in this shift. In the context of this
report, India had a low rate of smoking prevalence
(13%; data not presented in a table), but among the
highest rate of smoking persistence. Smoking may
not be currently common in India, but given the
low likelihood of an individual quitting smoking
once they start (i.e., high persistence), there
may be a large smoking epidemic years down the
line. High persistence indicates individuals are
not quitting, and the main changes in smoking
prevalence that are expected would be upward. A
marked gender difference in smoking prevalence
in India (data not presented in a table) is also con-
sistent with Lopezs model, that is, increases in
male smoking prevalence precede increases in fe-
male smoking prevalence.5. Conflicts of interest
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by WHO(India)and helped by Dr. R Chandrasekaran,
JIPMER. Implementation of the Iraq Mental Health
Survey (IMHS) and data entry were carried out by
the staff of the Iraqi MOH and MOP with direct sup-
port from the Iraqi IMHS team with funding from
both the Japanese and European Funds through
United Nations Development Group Iraq Trust Fund
(UNDG ITF). The Israel National Health Survey is
funded by the Ministry of Health with support from
the Israel National Institute for Health Policy and
Health Services Research and the National Insur-
ance Institute of Israel. The World Mental Health
Japan (WMHJ) Survey is supported by the Grant
for Research on Psychiatric and Neurological
Diseases and Mental Health (H13-SHOGAI-023,
142 J.P. Troost et al.H14-TOKUBETSU-026, H16-KOKORO-013) from the
Japan Ministry of Health, Labor and Welfare. The
Lebanese National Mental Health Survey (LEBA-
NON) is supported by the Lebanese Ministry of Pub-
lic Health, the WHO (Lebanon), Fogarty
International, anonymous private donations to
IDRAAC, Lebanon, and unrestricted grants from
Janssen Cilag, Eli Lilly, GlaxoSmithKline, Roche,
and Novartis. The Mexican National Comorbidity
Survey (MNCS) is supported by The National Insti-
tute of Psychiatry Ramon de la Fuente (INPRFMDIES
4280) and by the National Council on Science and
Technology (CONACyT-G30544- H), with supple-
mental support from the PanAmerican Health Orga-
nization (PAHO). Te Rau Hinengaro: The New
Zealand Mental Health Survey (NZMHS) is supported
by the New Zealand Ministry of Health, Alcohol
Advisory Council, and the Health Research Council.
The Nigerian Survey of Mental Health and Wellbe-
ing (NSMHW) is supported by the WHO (Geneva),
the WHO (Nigeria), and the Federal Ministry of
Health, Abuja, Nigeria. The Northern Ireland Study
of Mental Health was funded by the Health & Social
Care Research & Development Division of the Pub-
lic Health Agency. The Romania WMH study pro-
jects ‘‘Policies in Mental Health Area’’ and
‘‘National Study regarding Mental Health and Ser-
vices Use’’ were carried out by National School ofTable A1 Description of each country by covariates used in
heterogeneity of smoking persistence. Data from the World Me
Country % Persistent
smokers
SE (% Persistent
Smokers)
Nigeria 27.1 0.5
Colombia 37.9 0.9
Mexico 43.2 1.1
New Zealand 46.0 0.6
United States 47.5 0.8
Northern Ireland 52.1 1.2
Belgium 52.6 1.2
Brazil 53.0 1.1
France 53.4 1.3
Netherlands 53.5 1.2
Japan 54.4 1.2
Italy 57.8 1.1
Germany 61.0 1.1
Romania 64.2 1.2
Spain 65.0 0.9
Ukraine 70.8 0.8
South Africa 72.5 1.0
Bulgaria 73.8 1.8
India 75.1 0.7
Lebanon 77.3 1.8
China 84.0 1.2
1 Elapsed time since smoking onset stratification is not available
2 Income level defined by the World Bank.Public Health & Health Services Management (for-
mer National Institute for Research & Development
in Health), with technical support of Metro Media
Transilvania, the National Institute of Statistics-
National Center for Training in Statistics, SC.
Cheyenne Services SRL, Statistics Netherlands and
were funded by Ministry of Public Health (former
Ministry of Health) with supplemental support of
Eli Lilly Romania SRL. The South Africa Stress and
Health Study (SASH) is supported by the US National
Institute of Mental Health (R01-MH059575) and Na-
tional Institute of Drug Abuse with supplemental
funding from the South African Department of
Health and the University of Michigan. The Ukraine
Comorbid Mental Disorders during Periods of Social
Disruption (CMDPSD) study is funded by the US Na-
tional Institute of Mental Health (RO1-MH61905).
The US National Comorbidity Survey Replication
(NCS-R) is supported by the National Institute of
Mental Health (NIMH; U01-MH60220) with supple-
mental support from the National Institute of Drug
Abuse (NIDA), the Substance Abuse and Mental
Health Services Administration (SAMHSA), the Rob-
ert Wood Johnson Foundation (RWJF; Grant
044708), and the John W. Alden Trust.
A complete list of all within-country and cross-
national WMH publications can be found at
http://www.hcp.med.harvard.edu/wmh/.a meta regression testing for sources of between-country
ntal Health Surveys Consortium, 2001–2008.
% in Pre WWII
cohorts
% With onset
610 years1
Income level2
20.0 12.3 Lower-middle
11.7 21.2 Upper-middle
15.8 32.7 Upper-middle
25.9 N/A High
28.7 11.8 High
28.6 N/A High
26.2 N/A High
18.2 11.0 Upper-middle
22.7 N/A High
28.7 N/A High
32.9 N/A High
29.1 N/A High
26.0 N/A High
18.6 14.1 Upper-middle
22.6 N/A High
20.1 17.7 Lower-middle
13.1 35.2 Upper-middle
19.0 11.3 Upper-middle
22.0 17.4 Lower-middle
23.1 21.8 Upper-middle
18.7 17.4 Lower-middle
for sites that did not ask about the age of smoking onset.
Table A2 Summary of meta regressions on the effect of country level covariates on the cross-national variation in
smoking persistence. Data from the World Mental Health Surveys Consortium, 2001–2008.
No. of countries Coefficient SE(Coefficient) Z-score P-value
Crude
Lower-middle income 21 Ref Ref Ref Ref
Upper-middle income 21 4.97 9.00 0.44 0.659
High 21 9.89 8.50 1.16 0.244
Birth cohort1 21 0.23 0.58 0.40 0.689
Recency of onset2 12 0.19 0.71 0.27 0.786
Adjusted 1
Lower-middle income 21 Ref Ref Ref Ref
Upper-middle income 21 1.09 9.68 0.11 0.910
High income 21 16.24 11.33 1.43 0.152
Birth cohort1 21 0.90 1.07 0.86 0.392
Adjusted 2
Lower-middle income 12 Ref Ref Ref Ref
Upper-middle income 12 2.22 13.87 0.16 0.873
High income 12 39.57 28.19 1.40 0.160
Birth cohort1 12 3.04 2.25 1.35 0.176
Recency of onset2 12 0.70 0.89 0.16 0.877
NOTE: Meta regressions were first estimated with each covariate as a bivariate predictor. Multivariable analyses were separated
into two analyses. This was done because the onset was only available for 12 countries. The first adjusted regression provides
estimates for income level and birth cohort among all 21 countries; the second adjusted regression provides estimates for income
level, birth cohort and onset of smoking (among the 12 countries with data on the onset).
Income level was defined by the World Bank.
1 Percent of smokers in Pre-Second World War irth cohorts.
2 Percent of smokers with onsets within 10 years of survey assessment.
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